Benchmarking Patient Recruitment and Retention Practices.
Journal
Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
06
01
2020
accepted:
09
06
2020
pubmed:
18
6
2020
medline:
4
6
2021
entrez:
18
6
2020
Statut:
ppublish
Résumé
Patient recruitment and retention continue to present challenges in conducting clinical trials. The objectives of the study were to benchmark patient recruitment and retention practices across recent global clinical trials from a working group of biopharmaceutical companies and to re-visit the results from an earlier study published 7 years ago. The data collection focused on patient and site enrollment metrics and recruitment and retention tactics used for studies. Analyses were conducted comparing the results from 2012 and 2019. The results indicated that more studies met or exceeded planned enrollment than the previous research and global differences were observed in the present study for site activation rates and target to actual enrollment rates. Since an updated set of recruitment and retention tactics were evaluated in the present study, no comparisons were made to previous data. Researchers suggest further study that would examine usage and effectiveness of specific recruitment and retention tactics across global studies.
Identifiants
pubmed: 32548703
doi: 10.1007/s43441-020-00186-4
pii: 10.1007/s43441-020-00186-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
19-32Références
Lai G, Gary T, Tilburt J, et al. Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials. Clin Trials. 2006;3(2):133–41.
pubmed: 16773955
doi: 10.1191/1740774506cn143oa
Lamberti MJ, Mathias A, Myles JE, et al. Evaluating the impact of patient recruitment and retention practices. Therap Innov Regul Sci. 2012;46(5):573–80.
Sung N, Crowley W, Genel M, et al. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278–87.
pubmed: 12633190
doi: 10.1001/jama.289.10.1278
Treweek S, Lockhart P, Pitkelthy M, et al. Methods to improve recruitment to randomized controlled trials: Cochrane systematic review and meta-analysis. BMJ Open. 2013;3:3.
doi: 10.1136/bmjopen-2012-002360
Otobo E, Park S, Rogers J, et al. Reinventing inflammatory bowel disease (IBD) clinical trial recruitment using novel digital medicine tools. Gastroenterology. 2013;156(3):S28. https://doi.org/10.1053/j.gastro.2019.01.091 .
doi: 10.1053/j.gastro.2019.01.091
Weng C, Bigger JT, Busacca L. Comparing the effectiveness of a clinical registry and a clinical data warehouse for supporting clinical trial recruitment: a case study. AMIA Ann Symp Proc Arch. 2010;2010:867–81.
Stergiopoulos S, Michaels D, Lopez Kunz B, et al. Measuring the impact of patient engagement and patient centricity in clinical research and development. Therap Innov Regul Sci. 2019. https://doi.org/10.1177/2F2168479018817517 .
doi: 10.1177/2F2168479018817517
Housman LT. “I’m Home(screen)”: Social media in health care has arrived. Clin Ther. 2017;39(11):2189–95. https://doi.org/10.1016/j.clinthera.2017.10.007 .
pubmed: 29100731
doi: 10.1016/j.clinthera.2017.10.007
Nash E, Gilroy D, Srikusalanukul W, et al. Facebook advertising for participant recruitment into a blood pressure clinical trial. J Hypertens. 2017;35(12):2527–31. https://doi.org/10.1097/HJH.0000000000001477 .
pubmed: 28704263
doi: 10.1097/HJH.0000000000001477
Spoelstra S, Sikorskii A, Given C. Adult cancer patient recruitment and enrollment into cell phone text message trials. Telemed J E-Health. 2016;22(10):836–42. https://doi.org/10.1089/tmj.2015.0263 .
pubmed: 26982446
pmcid: 5087987
doi: 10.1089/tmj.2015.0263
Krischer J, Cronholm P. Burroughs C Experience with direct-to-patient recruitment for enrollment into a clinical trial in a rare disease: a web-based study. J Med Internet Res. 2017;19(2):e50.
pubmed: 28246067
pmcid: 5350442
doi: 10.2196/jmir.6798
Getz K, Campo R. New benchmarks characterizing growth in protocol design complexity. Therap Innov Regul Sci. 2018;52(1):22–8. https://doi.org/10.1177/2F2168479017713039 .
doi: 10.1177/2F2168479017713039
Getz K, Sethuraman V, Rine J, et al. Assessing patient participation burden based on protocol design characteristics. Therap Innov Regul Sci. 2019. https://doi.org/10.1177/2F2168479019867284 .
doi: 10.1177/2F2168479019867284
Ali S, Egunsola O, Babar Z, et al. Clinical trials in Asia: a World Health Organization database study. Perspect Clin Res. 2019;10(3):121–4.
pubmed: 31404203
pmcid: 6647899
doi: 10.4103/picr.PICR_109_18
Dece-Gomez HL, Pinto JA, Casteneda C, et al. Current barriers for developing clinical research in Latin America: a cross-sectional survey of medical oncologists. Clin Res Trials. 2015;1(2):22–8.